Stryker Corporation
SYKNYSEHealthcareMedical Devices
As of Oct 23, 2026 close
- Market cap
- $118.56B
- P/E (TTM)
- 31.79
- Forward P/E
- 24.90
- Dividend yield
- 1.15%
- 52-week range
- $267.00$392.55
- Volume (live)
- -
- Avg. volume (3M)
- 2.66M
Stryker (SYK) Stock Price & Financial Analysis
Stryker Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $305.00 - $309.57 |
|---|---|
| 52-Week High | $392.55 |
| 52-Week Low | $267.00 |
| Open | $305.01 |
| Volume (last close) | 1.98M |
| Average Volume (3M) | 2.66M |
| Revenue (TTM) | 25.84B |
|---|---|
| Net Income (TTM) | 3.73B |
| Free Cash Flow (TTM) | 4.70B |
| EPS (TTM) | $9.65 |
| Profit Margin | 14.43% |
| Operating Margin | 22.03% |
| Return on Equity (ROE) | 15.55% |
| Debt to Equity | 0.62 |
| Annual Dividend | $3.52 |
|---|---|
| Dividend Yield | 1.15% |
| Payout Ratio | 36.48% |
| Last Dividend Ex-Date | Sep 30, 2026 |
| Market Cap | 118.56B |
|---|---|
| Shares Outstanding | 386.00M |
| P/E Ratio (TTM) | 31.79 |
| Forward P/E | 24.90 |
| Price to Sales (P/S) | 4.59 |
| Price to Book (P/B) | 4.94 |
| EV/EBITDA | 18.23 |
| 50-Day MA | $298.30 |
|---|---|
| 200-Day MA | $326.16 |
| 1-Year Change | −19.84% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Stryker at a Glance
As of the Oct 23, 2026 close, Stryker (SYK) has a market capitalization of $118.56B. The stock trades at 31.8× trailing earnings, 24.9× forward earnings and 4.6× sales. Over the trailing twelve months it earned $3.73B on revenue of $25.84B (a 14.4% profit margin) and generated $4.70B of free cash flow. Revenue grew 8.5% year over year.
As of its latest reported balance sheet, it holds $3.39B in cash and securities against $14.94B of debt, a net debt position of $11.55B.
Stryker pays a quarterly dividend totaling $3.52 per share a year, a 1.15% yield at the Oct 23, 2026 close, with a 36% payout ratio and 27 consecutive years of dividend increases.
The share price is down 19.8% over the past year. At $307.15 (the Oct 23, 2026 close) it sits within its 52-week range of $267.00 to $392.55, below its 200-day moving average of $326.16.
Based on 26 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $368.00, 19.8% above the Oct 23, 2026 close.
Frequently Asked Questions About Stryker
What is the current stock price for SYK?
As of the Oct 23, 2026 close, SYK stock trades at $307.15. The 52-week range is $267.00–$392.55, with a day range of $305.00–$309.57.
What is the P/E ratio for SYK?
As of the Oct 23, 2026 close, Stryker's trailing twelve-month (TTM) P/E ratio is 31.8, meaning investors pay $31.8 for every $1 of annual earnings. The forward P/E is 24.9, reflecting analyst expectations for future earnings. Stryker operates in the Healthcare sector.
Does SYK pay dividends?
Yes, Stryker pays a 1.15% annual dividend yield as of the Oct 23, 2026 close ($3.52 per share a year). The trailing twelve-month payout ratio is 36.5%. The most recent ex-dividend date was September 30, 2026.
What do analysts recommend for SYK?
Based on ratings from 26 professional analysts over the last 90 days, the consensus for SYK is Buy. The average 12-month price target is $368.00, a 19.8% upside from the Oct 23, 2026 close of $307.15.
What is the market cap of SYK?
As of the Oct 23, 2026 close, Stryker's market capitalization is $118.56B, classifying it as a large-cap company. Stryker operates in the Healthcare sector within the Medical Devices industry.